Schedule 13G ownership disclosure

IONIS PHARMACEUTICALS INC

Common Stock · CUSIP: 462222100

Event date: 2024-12-31

Filing-level shares
16,472,539
Percent of class
10.43%
  • The Vanguard Group

    Shares: 16,472,539 · Class: 10.43%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000029
Form type
SCHEDULE 13G/A
Filer
IONIS PHARMACEUTICALS INC
CIK
CIK 874015
Filed
Jan 08, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub